ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-Acting Reversible Contraception(LARC) Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-20M15682
Home | Market Reports | Health| Reproductive Health
Global Long Acting Reversible Contraception LARC Market Research Report 2023
BUY CHAPTERS

Global Long-Acting Reversible Contraception(LARC) Market Research Report 2024

Code: QYRE-Auto-20M15682
Report
August 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Merck
Teva Pharmaceutical
Allergan plc
HRA Pharma
Eurogine
SMB Corporation
Shenyang Liren
Cooper Companies
AbbVie(Allergan)
Organon
Shanghai Dahua Pharmaceutical
Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
Wuxi Tianyi Medical Equipment Co., Ltd.
Tianjin Hejie Medical Equipment Co., Ltd.

Long-Acting Reversible Contraception(LARC) Market Size

The global Long-Acting Reversible Contraception(LARC) market was valued at US$ 1154 million in 2023 and is anticipated to reach US$ 1730.6 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.

Long-Acting Reversible Contraception(LARC) Market

Long-Acting Reversible Contraception(LARC) Market

Long-acting reversible pregnancy (LARC) is a birth control method that provides long-term pregnancy prevention. LARC can provide protection for three to 10 years or more.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Long-Acting Reversible Contraception(LARC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Reversible Contraception(LARC).

Report Scope

The Long-Acting Reversible Contraception(LARC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Long-Acting Reversible Contraception(LARC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-Acting Reversible Contraception(LARC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Long-Acting Reversible Contraception(LARC) Market Report

Report Metric Details
Report Name Long-Acting Reversible Contraception(LARC) Market
Accounted market size in 2023 US$ 1154 million
Forecasted market size in 2030 US$ 1730.6 million
CAGR 6.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Intrauterine Devices (IUCs)
  • Subcutaneous Implant
Segment by Application
  • Age 20~24 Years Old
  • Age 25-34 Years Old
  • Age 35~44 Years Old
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Merck, Teva Pharmaceutical, Allergan, HRA Pharma, Eurogine, Yantai Family Planning Pharmaceutical Equipment Co., Ltd., Wuxi Tianyi Medical Equipment Co., Ltd., SMB Corporation, Shenyang Liren, Tianjin Hejie Medical Equipment Co., Ltd., Cooper Companies, AbbVie Allergan, Organon, Shanghai Dahua Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-Acting Reversible Contraception(LARC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-Acting Reversible Contraception(LARC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Long-Acting Reversible Contraception(LARC) Market growing?

Ans: The Long-Acting Reversible Contraception(LARC) Market witnessing a CAGR of 6.0% during the forecast period 2024-2030.

What is the Long-Acting Reversible Contraception(LARC) Market size in 2030?

Ans: The Long-Acting Reversible Contraception(LARC) Market size in 2030 will be US$ 1730.6 million.

Who are the main players in the Long-Acting Reversible Contraception(LARC) Market report?

Ans: The main players in the Long-Acting Reversible Contraception(LARC) Market are Bayer, Merck, Teva Pharmaceutical, Allergan, HRA Pharma, Eurogine, Yantai Family Planning Pharmaceutical Equipment Co., Ltd., Wuxi Tianyi Medical Equipment Co., Ltd., SMB Corporation, Shenyang Liren, Tianjin Hejie Medical Equipment Co., Ltd., Cooper Companies, AbbVie Allergan, Organon, Shanghai Dahua Pharmaceutical

What are the Application segmentation covered in the Long-Acting Reversible Contraception(LARC) Market report?

Ans: The Applications covered in the Long-Acting Reversible Contraception(LARC) Market report are Age 20~24 Years Old, Age 25-34 Years Old, Age 35~44 Years Old, Other

What are the Type segmentation covered in the Long-Acting Reversible Contraception(LARC) Market report?

Ans: The Types covered in the Long-Acting Reversible Contraception(LARC) Market report are Intrauterine Devices (IUCs), Subcutaneous Implant

1 Long-Acting Reversible Contraception(LARC) Market Overview
1.1 Product Overview and Scope of Long-Acting Reversible Contraception(LARC)
1.2 Long-Acting Reversible Contraception(LARC) Segment by Type
1.2.1 Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Type (2024-2030)
1.2.2 Intrauterine Devices (IUCs)
1.2.3 Subcutaneous Implant
1.3 Long-Acting Reversible Contraception(LARC) Segment by Application
1.3.1 Global Long-Acting Reversible Contraception(LARC) Market Value by Application: (2024-2030)
1.3.2 Age 20~24 Years Old
1.3.3 Age 25-34 Years Old
1.3.4 Age 35~44 Years Old
1.3.5 Other
1.4 Global Long-Acting Reversible Contraception(LARC) Market Size Estimates and Forecasts
1.4.1 Global Long-Acting Reversible Contraception(LARC) Revenue 2019-2030
1.4.2 Global Long-Acting Reversible Contraception(LARC) Sales 2019-2030
1.4.3 Global Long-Acting Reversible Contraception(LARC) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Long-Acting Reversible Contraception(LARC) Market Competition by Manufacturers
2.1 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Long-Acting Reversible Contraception(LARC) Average Price by Manufacturers (2019-2024)
2.4 Global Long-Acting Reversible Contraception(LARC) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Product Type & Application
2.7 Long-Acting Reversible Contraception(LARC) Market Competitive Situation and Trends
2.7.1 Long-Acting Reversible Contraception(LARC) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Long-Acting Reversible Contraception(LARC) Players Market Share by Revenue
2.7.3 Global Long-Acting Reversible Contraception(LARC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Long-Acting Reversible Contraception(LARC) Retrospective Market Scenario by Region
3.1 Global Long-Acting Reversible Contraception(LARC) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Long-Acting Reversible Contraception(LARC) Global Long-Acting Reversible Contraception(LARC) Sales by Region: 2019-2030
3.2.1 Global Long-Acting Reversible Contraception(LARC) Sales by Region: 2019-2024
3.2.2 Global Long-Acting Reversible Contraception(LARC) Sales by Region: 2025-2030
3.3 Global Long-Acting Reversible Contraception(LARC) Global Long-Acting Reversible Contraception(LARC) Revenue by Region: 2019-2030
3.3.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Region: 2019-2024
3.3.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Region: 2025-2030
3.4 North America Long-Acting Reversible Contraception(LARC) Market Facts & Figures by Country
3.4.1 North America Long-Acting Reversible Contraception(LARC) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2030)
3.4.3 North America Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-Acting Reversible Contraception(LARC) Market Facts & Figures by Country
3.5.1 Europe Long-Acting Reversible Contraception(LARC) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2030)
3.5.3 Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-Acting Reversible Contraception(LARC) Market Facts & Figures by Country
3.6.1 Asia Pacific Long-Acting Reversible Contraception(LARC) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2030)
3.6.3 Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-Acting Reversible Contraception(LARC) Market Facts & Figures by Country
3.7.1 Latin America Long-Acting Reversible Contraception(LARC) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2030)
3.7.3 Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Long-Acting Reversible Contraception(LARC) Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-Acting Reversible Contraception(LARC) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-Acting Reversible Contraception(LARC) Sales by Type (2019-2030)
4.1.1 Global Long-Acting Reversible Contraception(LARC) Sales by Type (2019-2024)
4.1.2 Global Long-Acting Reversible Contraception(LARC) Sales by Type (2025-2030)
4.1.3 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2019-2030)
4.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2019-2030)
4.2.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2019-2024)
4.2.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2025-2030)
4.2.3 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2019-2030)
4.3 Global Long-Acting Reversible Contraception(LARC) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Long-Acting Reversible Contraception(LARC) Sales by Application (2019-2030)
5.1.1 Global Long-Acting Reversible Contraception(LARC) Sales by Application (2019-2024)
5.1.2 Global Long-Acting Reversible Contraception(LARC) Sales by Application (2025-2030)
5.1.3 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2019-2030)
5.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2019-2030)
5.2.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2019-2024)
5.2.2 Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2025-2030)
5.2.3 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2019-2030)
5.3 Global Long-Acting Reversible Contraception(LARC) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Long-Acting Reversible Contraception(LARC) Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Long-Acting Reversible Contraception(LARC) Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Teva Pharmaceutical
6.3.1 Teva Pharmaceutical Corporation Information
6.3.2 Teva Pharmaceutical Description and Business Overview
6.3.3 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolio
6.3.5 Teva Pharmaceutical Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Long-Acting Reversible Contraception(LARC) Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 HRA Pharma
6.5.1 HRA Pharma Corporation Information
6.5.2 HRA Pharma Description and Business Overview
6.5.3 HRA Pharma Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolio
6.5.5 HRA Pharma Recent Developments/Updates
6.6 Eurogine
6.6.1 Eurogine Corporation Information
6.6.2 Eurogine Description and Business Overview
6.6.3 Eurogine Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolio
6.6.5 Eurogine Recent Developments/Updates
6.7 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
6.6.1 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Corporation Information
6.6.2 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Description and Business Overview
6.6.3 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolio
6.7.5 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Recent Developments/Updates
6.8 Wuxi Tianyi Medical Equipment Co., Ltd.
6.8.1 Wuxi Tianyi Medical Equipment Co., Ltd. Corporation Information
6.8.2 Wuxi Tianyi Medical Equipment Co., Ltd. Description and Business Overview
6.8.3 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolio
6.8.5 Wuxi Tianyi Medical Equipment Co., Ltd. Recent Developments/Updates
6.9 SMB Corporation
6.9.1 SMB Corporation Corporation Information
6.9.2 SMB Corporation Description and Business Overview
6.9.3 SMB Corporation Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolio
6.9.5 SMB Corporation Recent Developments/Updates
6.10 Shenyang Liren
6.10.1 Shenyang Liren Corporation Information
6.10.2 Shenyang Liren Description and Business Overview
6.10.3 Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolio
6.10.5 Shenyang Liren Recent Developments/Updates
6.11 Tianjin Hejie Medical Equipment Co., Ltd.
6.11.1 Tianjin Hejie Medical Equipment Co., Ltd. Corporation Information
6.11.2 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Description and Business Overview
6.11.3 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolio
6.11.5 Tianjin Hejie Medical Equipment Co., Ltd. Recent Developments/Updates
6.12 Cooper Companies
6.12.1 Cooper Companies Corporation Information
6.12.2 Cooper Companies Long-Acting Reversible Contraception(LARC) Description and Business Overview
6.12.3 Cooper Companies Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolio
6.12.5 Cooper Companies Recent Developments/Updates
6.13 AbbVie Allergan
6.13.1 AbbVie Allergan Corporation Information
6.13.2 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Description and Business Overview
6.13.3 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolio
6.13.5 AbbVie Allergan Recent Developments/Updates
6.14 Organon
6.14.1 Organon Corporation Information
6.14.2 Organon Long-Acting Reversible Contraception(LARC) Description and Business Overview
6.14.3 Organon Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Organon Long-Acting Reversible Contraception(LARC) Product Portfolio
6.14.5 Organon Recent Developments/Updates
6.15 Shanghai Dahua Pharmaceutical
6.15.1 Shanghai Dahua Pharmaceutical Corporation Information
6.15.2 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Description and Business Overview
6.15.3 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolio
6.15.5 Shanghai Dahua Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-Acting Reversible Contraception(LARC) Industry Chain Analysis
7.2 Long-Acting Reversible Contraception(LARC) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-Acting Reversible Contraception(LARC) Production Mode & Process
7.4 Long-Acting Reversible Contraception(LARC) Sales and Marketing
7.4.1 Long-Acting Reversible Contraception(LARC) Sales Channels
7.4.2 Long-Acting Reversible Contraception(LARC) Distributors
7.5 Long-Acting Reversible Contraception(LARC) Customers
8 Long-Acting Reversible Contraception(LARC) Market Dynamics
8.1 Long-Acting Reversible Contraception(LARC) Industry Trends
8.2 Long-Acting Reversible Contraception(LARC) Market Drivers
8.3 Long-Acting Reversible Contraception(LARC) Market Challenges
8.4 Long-Acting Reversible Contraception(LARC) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Merck
Teva Pharmaceutical
Allergan plc
HRA Pharma
Eurogine
SMB Corporation
Shenyang Liren
Cooper Companies
AbbVie(Allergan)
Organon
Shanghai Dahua Pharmaceutical
Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
Wuxi Tianyi Medical Equipment Co., Ltd.
Tianjin Hejie Medical Equipment Co., Ltd.
List of Tables
    Table 1. Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Long-Acting Reversible Contraception(LARC) Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Long-Acting Reversible Contraception(LARC) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Long-Acting Reversible Contraception(LARC), Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Product Type & Application
    Table 12. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Long-Acting Reversible Contraception(LARC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Reversible Contraception(LARC) as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Long-Acting Reversible Contraception(LARC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2019-2024) & (K Units)
    Table 18. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2019-2024)
    Table 19. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2025-2030) & (K Units)
    Table 20. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2025-2030)
    Table 21. Global Long-Acting Reversible Contraception(LARC) Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2019-2024)
    Table 23. Global Long-Acting Reversible Contraception(LARC) Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2025-2030)
    Table 25. North America Long-Acting Reversible Contraception(LARC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2024) & (K Units)
    Table 27. North America Long-Acting Reversible Contraception(LARC) Sales by Country (2025-2030) & (K Units)
    Table 28. North America Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Long-Acting Reversible Contraception(LARC) Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Long-Acting Reversible Contraception(LARC) Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Long-Acting Reversible Contraception(LARC) Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) by Type (2019-2024)
    Table 51. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) by Type (2025-2030)
    Table 52. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2019-2024)
    Table 53. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2025-2030)
    Table 54. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2019-2024)
    Table 57. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2025-2030)
    Table 58. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) by Application (2019-2024)
    Table 61. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) by Application (2025-2030)
    Table 62. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2019-2024)
    Table 63. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2025-2030)
    Table 64. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2019-2024)
    Table 67. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2025-2030)
    Table 68. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Application (2025-2030)
    Table 70. Bayer Corporation Information
    Table 71. Bayer Description and Business Overview
    Table 72. Bayer Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Bayer Long-Acting Reversible Contraception(LARC) Product
    Table 74. Bayer Recent Developments/Updates
    Table 75. Merck Corporation Information
    Table 76. Merck Description and Business Overview
    Table 77. Merck Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Merck Long-Acting Reversible Contraception(LARC) Product
    Table 79. Merck Recent Developments/Updates
    Table 80. Teva Pharmaceutical Corporation Information
    Table 81. Teva Pharmaceutical Description and Business Overview
    Table 82. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product
    Table 84. Teva Pharmaceutical Recent Developments/Updates
    Table 85. Allergan Corporation Information
    Table 86. Allergan Description and Business Overview
    Table 87. Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Allergan Long-Acting Reversible Contraception(LARC) Product
    Table 89. Allergan Recent Developments/Updates
    Table 90. HRA Pharma Corporation Information
    Table 91. HRA Pharma Description and Business Overview
    Table 92. HRA Pharma Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. HRA Pharma Long-Acting Reversible Contraception(LARC) Product
    Table 94. HRA Pharma Recent Developments/Updates
    Table 95. Eurogine Corporation Information
    Table 96. Eurogine Description and Business Overview
    Table 97. Eurogine Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Eurogine Long-Acting Reversible Contraception(LARC) Product
    Table 99. Eurogine Recent Developments/Updates
    Table 100. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Corporation Information
    Table 101. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Description and Business Overview
    Table 102. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
    Table 104. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Recent Developments/Updates
    Table 105. Wuxi Tianyi Medical Equipment Co., Ltd. Corporation Information
    Table 106. Wuxi Tianyi Medical Equipment Co., Ltd. Description and Business Overview
    Table 107. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
    Table 109. Wuxi Tianyi Medical Equipment Co., Ltd. Recent Developments/Updates
    Table 110. SMB Corporation Corporation Information
    Table 111. SMB Corporation Description and Business Overview
    Table 112. SMB Corporation Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. SMB Corporation Long-Acting Reversible Contraception(LARC) Product
    Table 114. SMB Corporation Recent Developments/Updates
    Table 115. Shenyang Liren Corporation Information
    Table 116. Shenyang Liren Description and Business Overview
    Table 117. Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Shenyang Liren Long-Acting Reversible Contraception(LARC) Product
    Table 119. Shenyang Liren Recent Developments/Updates
    Table 120. Tianjin Hejie Medical Equipment Co., Ltd. Corporation Information
    Table 121. Tianjin Hejie Medical Equipment Co., Ltd. Description and Business Overview
    Table 122. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
    Table 124. Tianjin Hejie Medical Equipment Co., Ltd. Recent Developments/Updates
    Table 125. Cooper Companies Corporation Information
    Table 126. Cooper Companies Description and Business Overview
    Table 127. Cooper Companies Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Cooper Companies Long-Acting Reversible Contraception(LARC) Product
    Table 129. Cooper Companies Recent Developments/Updates
    Table 130. AbbVie Allergan Corporation Information
    Table 131. AbbVie Allergan Description and Business Overview
    Table 132. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product
    Table 134. AbbVie Allergan Recent Developments/Updates
    Table 135. Organon Corporation Information
    Table 136. Organon Description and Business Overview
    Table 137. Organon Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Organon Long-Acting Reversible Contraception(LARC) Product
    Table 139. Organon Recent Developments/Updates
    Table 140. Shanghai Dahua Pharmaceutical Corporation Information
    Table 141. Shanghai Dahua Pharmaceutical Description and Business Overview
    Table 142. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product
    Table 144. Shanghai Dahua Pharmaceutical Recent Developments/Updates
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Long-Acting Reversible Contraception(LARC) Distributors List
    Table 148. Long-Acting Reversible Contraception(LARC) Customers List
    Table 149. Long-Acting Reversible Contraception(LARC) Market Trends
    Table 150. Long-Acting Reversible Contraception(LARC) Market Drivers
    Table 151. Long-Acting Reversible Contraception(LARC) Market Challenges
    Table 152. Long-Acting Reversible Contraception(LARC) Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Long-Acting Reversible Contraception(LARC)
    Figure 2. Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Long-Acting Reversible Contraception(LARC) Market Share by Type in 2023 & 2030
    Figure 4. Intrauterine Devices (IUCs) Product Picture
    Figure 5. Subcutaneous Implant Product Picture
    Figure 6. Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Long-Acting Reversible Contraception(LARC) Market Share by Application in 2023 & 2030
    Figure 8. Age 20~24 Years Old
    Figure 9. Age 25-34 Years Old
    Figure 10. Age 35~44 Years Old
    Figure 11. Other
    Figure 12. Global Long-Acting Reversible Contraception(LARC) Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Long-Acting Reversible Contraception(LARC) Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Long-Acting Reversible Contraception(LARC) Sales (2019-2030) & (K Units)
    Figure 15. Global Long-Acting Reversible Contraception(LARC) Average Price (US$/Unit) & (2019-2030)
    Figure 16. Long-Acting Reversible Contraception(LARC) Report Years Considered
    Figure 17. Long-Acting Reversible Contraception(LARC) Sales Share by Manufacturers in 2023
    Figure 18. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Long-Acting Reversible Contraception(LARC) Players: Market Share by Revenue in 2023
    Figure 20. Long-Acting Reversible Contraception(LARC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Long-Acting Reversible Contraception(LARC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2019-2030)
    Figure 23. North America Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2019-2030)
    Figure 24. United States Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2019-2030)
    Figure 27. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2019-2030)
    Figure 35. China Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Southeast Asia Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Long-Acting Reversible Contraception(LARC) by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Long-Acting Reversible Contraception(LARC) by Type (2019-2030)
    Figure 54. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Long-Acting Reversible Contraception(LARC) by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Long-Acting Reversible Contraception(LARC) by Application (2019-2030)
    Figure 57. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Application (2019-2030)
    Figure 58. Long-Acting Reversible Contraception(LARC) Value Chain
    Figure 59. Long-Acting Reversible Contraception(LARC) Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Vitrification Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14N15115
Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Neonatal and Obstetric Monitoring Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-25J14588
Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Latex Dipping Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11B15328
Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Fetal Fibronectin Test Diagnostic Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35E14914
Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions